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inflammation of mice likely through enhancing
IL-10 and down-regulation of IL-5 and IL-17A
Hui Wang1, Jun Li1,2, Hongwei Pu1, Bilal Hasan3, Jinfeng Ma4, Malcolm K Jones5, Kan Zheng1, Xue Zhang1,
Haimei Ma1, Donald P McManus6, Renyong Lin1, Hao Wen1* and Wenbao Zhang1*Abstract
Background: Cystic echinococcosis (CE) is a near cosmopolitan zoonosis caused by the larval stage of the dog
tapeworm Echinococcus granulosus. E. granulosus infection induces a polarized T-helper type 2 (Th2) systematic
immune response in its intermediate hosts. However, it is not known whether the infection modulates lung inflammation
by regulating local immune response. In this study, we examined the effects of E. granulosus infection on mouse
ovalbumin (OVA)-induced asthma model.
Methods: BALB/c mice were intraperitoneally transplanted with 50 small E. granulosus cysts cultured in vitro. At
3 months post-inoculation, the mice were sensitized and challenged with ovalbumin (OVA). For histopathological
studies, hematoxylin eosin and periodic acid schiff staining was used to examine the inflammatory cells infiltration
and goblet cells hyperplasia, respectively. Cytokine levels were measured by mouse cytometric bead array (CBA)
Kit and quantitative RT-PCR and other molecular biological approaches. Airway hyperresponsiveness was assessed
in response to increasing doses of methacholine. Serum immunoglobulins were determined by ELISA.
Results: E. granulosus infection significantly increased Th2 and Treg cytokine levels in serum and lung tissues, but
down-regulated the expression of IL-5 in the lungs and IL-17A in serum and lung tissues of asthmatic mice sensitized
and challenged with OVA. Histological staining of lung tissues showed that E. granulosus infection significantly reduced
the severity of OVA-induced airway inflammation including reduction of eosinophil cell infiltration and mucus
production. The E. granulosus infection also reduced eosinophil accumulation induced by OVA in bronchoalveolar
lavage fluid (BALF) and also ameliorated airway hyperresponsiveness, a hallmark symptom of asthma.
Conclusions: E. granulosus infection remarkably reduces the severity of OVA-induced airway inflammation likely
through enhancing IL-10 and down-regulation of IL-5 and IL-17A.
Keywords: Allergic asthma, Echinococcus granulosus, Cystic echinococcosis, IL-5, IL-10, IL-17A, Airway inflammationBackground
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caused by the larval stage of the dog tapeworm Echinococcus
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environmental factors [3]. Sero-epidemiological surveys
in the hyper-endemic areas of highland Peru and western
China, have revealed 10-30% seropositivity in villagers
[4-6], indicating that large numbers of individuals are
exposed to E. granulosus infection in these communities,
even though only 1-9% of the population have cysts de-
tected by ultrasonography [7,8]. One significant feature of
CE is the fact that the larval cysts of E. granulosus are able
to survive in intermediate hosts for a very long time (up to
53 years in humans) without apparently causing patho-
logical damage in host tissues surrounding the cyst [9,10],td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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response towards a chronic state. In fact, it has been
shown that E. granulosus cysts induce an early (in the
first two weeks) Th1-type cytokine profile (IFN-gamma
and IL-2), followed by a shift toward a Th2-type profile
(IL-4, IL-5, IL-6, IL-10 and IL-13) in a mouse model
[10-12]. CE patients normally show a predominant Th2
profile and also found an elevated serum IgE [13]. Nor-
mally a Th2 response and IgE are associated with an in-
crease in asthmatic responses [14,15]; therefore, an E.
granulosus infection is likely to boost the airway allergic
response. However, there are no reports that show that
inhabitants living in E. granulosus -endemic areas are at
increased risk of allergic disease. Whereas schistosomiasis,
caused by trematode blood flukes, is characteristically as-
sociated with a predominant Th2 cytokine production
combining eosinophilic and IgE responses [16], schisto-
some infections ameliorate atopic disorders in humans
[17,18]. Furthermore, epidemiological studies have shown
that inhabitants in schistosomiasis-endemic areas had less
incidence of asthma, compared with those living in non-
endemic regions [19]. This phenomenon was first demon-
strated in mouse models of Schistosoma mansoni [20] and
the nematode, Trichinella spiralis [21], which showed that
these infections protected mice from OVA-induced airway
reactivity.
In this study, we used our established secondary CE
infection mouse model [22] to determine whether E.
granulosus infection can impact on allergic asthma in-
flammatory responses induced by ovalbumin (OVA). We
showed that the infection significantly suppressed OVA-
induced eosinophilic airway inflammation through enhan-
cing the level of IL-10 and down-regulation of IL-17A. As
far as we are aware, this is the first report of a study on




Pathogen-free female BALB/c mice, aged 6–8 weeks
(about 20 g in weight), were purchased from Beijing Vital
River Laboratory Animal Technology Company Limited,
and raised in the animal facility of the First Affiliated Hos-
pital of Xinjiang Medical University (FAH-XMU). All ex-
perimental protocols involving mice were approved by the
Ethical Committee of FAH-XMU (Approval No IACUC-
20120625003).
Animal infection and murine models of allergic asthma
All BALB/c mice were randomly divided into four groups
with 10 mice in each group comprising: (1) negative control
group administrated with PBS only (PBS); (2) E. granulosus
infection group (Eg); (3) ovalbumin (OVA) sensitization
and challenge group (OVA); (4) E. granulosus infectionplus OVA sensitization and challenge group (Eg +OVA).
To obtain mice successfully infected with hydatid cysts,
we pre-cultured E. granulosus protoscoleces in vitro,
which generated small cysts (200–300 μm in diameter),
as previously described [22]. The mice in Eg and Eg +OVA
groups were each intraperitoneally (i.p) transplanted with
50 small hydatid cysts, suspended in 0.4 mL of RPMI 1640
medium, using a 1.0 mL syringe assembled with a 20 gauge
needle. After 90 d of cyst transplantation, two groups
(Eg +OVA and OVA) of mice were each sensitized by in-
traperitoneal (i.p.) injections with 100 μg of OVA (Sigma–
Aldrich, St. Louis, MO, USA) on days 91 and 104 post-
cyst-transplantation mixed with 1 mg of aluminum
hydroxide (Sigma–Aldrich) in 200 μL of PBS. These two
groups of mice were then challenged with 2% (w/v) OVA
in PBS via the airway and the oral route for 30 min using
a nebulizer each day for 3 d from day 111 to day 113.
Negative control and E. granulosus infection group mice
were sensitized and challenged with PBS only.
Measuring airway hyperresponsiveness (AHR) to
methacholine
The day after the final OVA challenge, the mice were
analyzed using non-invasive lung function measurements
(BUXCO WBP, USA) to assess AHR. The pulmonary as-
sessment of enhanced pause (Penh) value was assessed by
barometric whole body plethysmography in response to in-
creasing doses of aerosolized methacholine (Mch) (acetyl β-
methylcholine chloride; Sigma-Aldrich) challenge. Briefly,
the mice were permitted to acclimate for 5 min, PBS
aerosol was administered to establish baseline readings
over 3 min, and then mice were subsequently treated
with a series of increasing concentrations (0, 3.125, 6.25,
12.5, 25, 50 mg/mL) of Mch for 2 min each dose to induce
bronchoconstriction. After each nebulization, recordings
were obtained for 3 min, and the Penh values measured
during each 3 min period were averaged. Results were
expressed as the percentage increase in Penh following
challenge with each increasing concentration of Mch.
Twenty-four hours later, mice were euthanized with car-
bon dioxide and samples including lung tissues, spleen,
BALF and blood (see the following sections for details)
were taken for further immunological analysis.
Bronchoalveolar lavage fluid (BALF)
BALF was collected by cannulating the trachea and lava-
ging the mouse lungs with 1.5 mL of cold PBS. The re-
covered BALF samples were centrifuged at 1500 rpm for
5 min at 4°C and then the cell pellets were resuspended
in 800 μL of PBS and centrifuged for 5 min at 1500 rpm
at 4°C. The cells were resuspended with 100 μL of PBS for
counting numbers of eosinophils, neutrophils, lymphocytes,
and macrophages using a Blood Corpuscle Analyzer
(Mindray BC-5300Vet, ShenZhen, China).
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For histopathological studies, the lung tissues of the mice
were fixed in 4% (v/v) paraformaldehyde in PBS and
paraffin-embedded for sectioning. Serial sections of 5 μm
thickness were cut and stained with hematoxylin and eosin
(H&E) to examine inflammatory cell infiltration and
changes in general histology. The sections were also
stained with Periodic Acid Schiff reagent (PAS) (BASO
Diagnostic, Zhuhai, China) to examine goblet cell hyper-
plasia in the bronchial epithelium. The severity of inflam-
matory cell infiltration was determined by counting blindly
the number of peribronchial eosinophils using the 5-point
scoring system described by Myou et al. [23], as follows:
0- no eosinophils infiltrated; 1- mild with few eosinophils
infiltrated; 2- medium with discontinuous single layer of
eosinophils attached to the peribronchial zones; 3- moder-
ate infiltrate, with one layer of eosinophils around the
peribronchial zones and 4- marked infiltrate, with more
than one layer of eosinophils and a changed morphology
of peribronchial zones.
To determine the extent of mucus production, goblet
cell hyperplasia in the airway epithelium was quantified
blindly using the 5-point grading system described by
Tanaka et al. [24]. The adopted grading system was: 0-
no goblet cells; 1- <25% goblet cells in cell population; 2-
25–50%; 3- 50–75%; 4- > 75% of goblet cells. Scoring of
inflammatory cells and goblet cells was performed in at
least three different fields for each lung section. All the
pathology sections were subjected to blind examination by
two pathologists.
Cell preparation
Mice were sacrificed 24 h after Mch challenge, Peritoneal
exudate cells (PECs) were harvested by thorough washing
of the peritoneal cavity with 5–6 mL of PBS for three
times. The recovered PECs were centrifuged at 1500 rpm
for 5 min at 4°C and the cell pellets were resuspended in
100 μL of PBS in order to count eosinophils, neutrophils,
lymphocytes, and macrophages using the same protocol
and instrument as described in BALF section. To isolate
splenocytes, spleens were squeezed using a plunger of a
5 mL syringe on a 70 μm cell strainer (BD Biosciences,
CA, USA) placed in a Petri-dish containing 1 ~ 2 mL RPMI
1640. The pass-through tissues were suspended with
10 mL of PBS and transferred into a 15 mL centrifuge
tube. After centrifugation, the cell pellet was resuspended
and hemolyzed with 10 mL of 1 × RBC lysis buffer. The
cells were resuspended in RPMI 1640 after a further wash
with PBS.
Flow cytometry
The splenocytes were resuspended in FBS buffer (BD Phar-
mingen, San José, CA, USA). For staining and counting
CD4+CD25+FoxP3+ cells, spleen cells were treated usingthe provided protocol of the Mouse Regulatory T Cell
Staining Kit (BD Biosciences). For CD4+IL-17A+ staining,
a concentration of 1 × 106 cells/mL in media were stimu-
lated with PMA/Ionomycin (at 50 ng/mL and 1 μg/mL
respectively) in the presence of BD GolgiStop™ Protein
Transport Inhibitor for 5 h. Then the cells were collected
and stained using anti-mouse antibodies, FITC-CD4 and
PE-IL-17A (BD Biosciences). The cells were protected from
light throughout the staining procedure and storage.
The fluorochrome intensity was measured by a FACS
Aria II flow cytometer (BD Biosciences) and analyzed
using CellQuest software (BD Biosciences).
Measurement of cytokines in the culture of spleen cells
and serum
Single-cell suspensions of splenocytes (1 × 107cells/mL/well)
were plated in 24-well tissue culture plates in RPMI 1640
(Gibico) supplemented with 10% (v/v) heat-inactivated FBS
(Gibico), 100 U/mL penicillin, and 100 μg/mL streptomycin
(Hyclone), and cultured alone or with Con A (5 μg/mL;
Sigma-Aldrich) at 37°C in an atmosphere of 5% CO2 in air
for 3 d. The culture supernatants were collected, centrifuged
at 2500 × g for 5 min at 4°C, and cytokine levels were
measured by mouse cytometric bead array (CBA) Kit
(BD Biosciences). Briefly, 50 μL of samples (splenocyte
culture and serum) or known concentrations of stand-
ard samples (0–5000 pg/mL) were added to a mixture
of 50 μL each of capture antibody bead reagent and
phycoerythrin (PE)-conjugated detection antibody. The
mixture was then incubated for 2 h at room temperature
in the dark and then washed to remove unbound detec-
tion antibody. Data were acquired using a FACS AriaIIflow
cytometer and analyzed using CBA software 1.1 (BD
Biosciences).
Quantitative RT-PCR
Total RNA was isolated from the lung tissues of mice
using Trizol reagent. After removing contaminated DNA
from the isolated RNA using DNaseI (Fermentas, Vilnius,
Lithuania), 1 μg of total RNA was reverse transcribed
into cDNA in 20 μL reaction mixtures containing 200 U
of moloneymurine leukemia virus reverse transcriptase
(MMLV, Promega, Madison, USA); 100 ng of oligo (dT)
primers; and 0.5 mM each of dNTPs. The resulting tem-
plates were quantified by real-time PCR (iQ5, Bio-Rad,
Hercules, CA) using SYBR Green PCR Kit (Qiagen, Cat.
No 204054) in conjunction with mouse gene-specific
primers for IL-2, IL-4, IL-5, IL-17A, IL-10, IFN-γ and
GAPDH (Additional file 1: Table S1).
For each sample, both the housekeeping and the target
genes were amplified in triplicates using the following
cycle scheme: initial denaturation of the samples at 95°C
for 15 min; 40 cycles at 95°C for 15 s,60°C for 30 s and
72°C for 30 s. Fluorescence was measured during every
Wang et al. Parasites & Vectors 2014, 7:522 Page 4 of 13
http://www.parasitesandvectors.com/content/7/1/522cycle, and a melting curve was used to analyze the speci-
ficity and purity of PCR products amplified by increasing
the temperature from 55 to 95°C (in 0.5°C increments).
A defined single peak was used to confirm the specificity
of the amplification. We used the serial dilution PCR
products of IL-2, IL-4, IL-5, IL-17A, IL-10, IFN-γ and
GAPDH for making their respective standard curve. The
relative gene expression values were normalized to the
expression values of GAPDH within each of the samples.
Western blot analysis
Fifty mg of lung tissue from each mouse was suspended in
RIPA buffer (Bio Teke Corporation, Beijing) for 30 min on
ice to isolate proteins for Western blot analysis. The lung
tissue was then homogenized using a Polytron (PRO
Scientific Lnc, Oxford). After centrifugation, each super-
natant obtained from the tissue extract containing 50 μg of
total proteins was separated using 12% (w/v) SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and
then electrophoretically transferred to a PVDF mem-
brane (Amersham Biosciences, Buckinghamshire, UK).
The membranes were incubated for 60 min at room
temperature with the appropriate primary antibodies:
anti-eosinophil major basic protein (EMBP) (dilution
1:200, Santa Cruz Biotechnology, Santa Cruz, CA), anti-
IL-5 (dilution 1:800) (Bioworld Technology, St. Louis Park,
MN, USA), IFN-γ (dilution 1:200, proteintech, Chicago,
USA), and anti-GAPDH (dilution 1:1000, Cell Signaling
technology, MA, USA). Immunoreactivity was detected
using the WesternBreeze Kit (Invitrogen, CA, USA). The
expression levels of respective proteins (in “relative units”)
in the lungs of the PBS control group, E. granulosus infec-
tion group, Eg +OVA group and OVA group mice were
quantified using Quantity One software (Bio-Rad) after
scanning of the Western blot membranes. In the method,
the band intensities reflected the average intensity of tar-
get protein over the area of the band normalized with that
of GAPDH.
Determination of serum immunoglobulin by ELISA
A standard microwell enzyme-linked immunosorbent assay
(ELISA) was performed [25] to determine specific immuno-
globulin antibody levels (IgG, IgG1, IgG2a, IgG2b, IgE)
against hydatid cyst fluid (HCF) antigens and OVA-specific
immunoglobulins (IgG1, IgG2a, IgE) in serum. HCF was
collected from sheep hydatid cysts and concentrated 10
times using a vacuum dryer. ELISA plates (Costar, NY)
were coated with HCF(10 μg/mL)or OVA(1 μg/mL), re-
spectively. The sera were diluted with 1% (w/v) BSA to
1:200 for the detection of IgG and 1: 50 for IgE; the
plates were incubated at 37°C for either 1 h (IgG) or
overnight (IgE) at 4°C. The plates were then washed four
times with PBS containing 0.1% Tween 20 (PBST), followed
by adding second antibody conjugated with horse radishperoxidase (HRP) including goat anti-mouse IgG or IgG
subclass (IgG1, IgG2a, gG2b) at 1:3000 and, goat anti-
mouse IgE at 1:2500. The plates were then incubated for
1 h at 37°C, except for the detection of IgE levels where the
plates were incubated overnight at 4°C. The plates were
washed five times with PBST. The assays were devel-
oped in 2, 2-azino-di-(ethyl-benzithiozolinsulpho-nate)
(ABTS) (Sigma) substrate solution for 30 min. The optical
density (OD) of the color that developed in the plate was
read at 405 nm using an ELISA reader (Thermo, MA,
USA USA).
Statistical analysis
Data were analyzed using the GraphPad Prism 5 software
(Graph-Pad Software, Inc., USA). All values are presented
as the means ± S.E.M (standard error of the mean).
Statistical differences between groups were determined by
One-way ANOVA followed by a Tukey’s test. Statistic sig-
nificances were accepted when p <0.05.
Results
Infection model of E. granulosus
To obtain an even number of hydatid cysts in mice, we
pre-cultured protoscoleces of E. granulosus into small
hydatid cysts with an average diameter of 250 μm. We
then intraperitoneally transplanted 50 of the small cysts
into each of BALB/c mice. All the mice necropsied at 115
d post-inoculation were successfully infected with hydatid
cysts, with a mean of 34.9 (20–49) cysts per mouse. The
cysts were only existed in the peritoneal cavity of the mice.
The procedure thus generated about 70% of cyst recovery
with 100% of mice infected, showing a stable mouse infec-
tion model had been established. The mean diameter of
the cysts was 4.4 ± 1.8 mm with the largest cyst being
18 mm in diameter.
Effect of E. granulosus infection against OVA-induced
eosinophil recruitment
To determine whether E. granulosus infection impacts on
asthma progression given that the infection significantly
regulates the host immune response [11,12], the mice in-
fected with E. granulosus cysts were sensitized and chal-
lenged with OVA. The numbers of eosinophils in BALF,
PECs and blood of the mice were counted 24 h after the
last OVA aerosol challenge. Figure 1A showed there was a
significant increase of eosinophils in the BALF of OVA
challenged mice compared with that of the PBS controls;
Eg +OVA mice did not have significantly increased num-
bers of eosinophils compared with the OVA challenged
mice. In contrast, the numbers of neutrophils, macro-
phages, and lymphocytes were not significant difference
between all groups of mice (data not shown). Figure 1B
shows that blood eosinophil counts were also signifi-
cantly increased in OVA challenged mice but not in PECs
Figure 1 Effect of E. granulosus infection on OVA-induced eosinophil recruitment and airway hyperresponsiveness. Samples collected
from the BALF (A), blood (B) and PECs (C) of mice sensitized and challenged 24 h after the last OVA challenge(n = 5). The enhanced pause (Penh) was
evaluated at baseline and after treatment with increasing doses of aerosolized methacholine (0–50 mg/ml). *, significant difference from OVA group,
p <0.05 (D). OVA, ovalbumin; BALF, bronchoalveolar lavage fluid; PECs, peritoneal exudate cells; control, PBS control group; Eg, E. granulosus infection
group; Eg + OVA, E. granulosu infection plus OVA-induced asthmatic group; OVA ,OVA-induced asthmatic group. *p <0.05; **p <0.01.
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cantly increased in the PECs in E. granulosus-infected
mice compared with those in PBS control mice, indicating
the lesions or the cysts may attract macrophages (data not
shown).
Effect of E. granulosus infection on airway
hyperresponsiveness (AHR)
To evaluate the inhibitory effects of E. granulosus infec-
tion on AHR, the Penh was assessed by barometric whole
body plethysmography in response to increasing doses of
aerosolized Mch challenge. OVA-challenged mice showed
a dose-dependent increase in the Penh values compared
with the control mice after Mch inhalation (from 0 mg/mL
to 50 mg/mL). However, the Penh values were lower in the
mice infected with E. granulosus and OVA sensitized
and challenged compared with the values of OVA mice.
E. granulosus infected mice without exposure to OVA
had no spontaneous AHR (Figure 1D).
Histopathological analysis of the effect of E. granulosus
infection on OVA-induced eosinophil infiltration and
mucus production
To further analyze the effects of E. granulosus infection on
the histopathology of airway allergic inflammation re-
sponses induced by OVA, the lung tissues of the mice
were histologically examined 24 h after challenge withMch. The analysis showed that E. granulosus infection
did not induce obvious changes in histology and path-
ology compared with the control mice. By contrast, OVA
induced a marked infiltration of inflammatory cells, mainly
eosinophils, into the peribronchiolar and perivascular
regions of the lungs. For the Eg + OVA mouse group,
only minimal cellular infiltration was noted around the
bronchioles, with a smaller average infiltration of inflam-
matory cells (Figure 2A, B). PAS staining was performed
on lung tissues to analyze the effects of E. granulosus
infection on the hyperplasia of goblet cells in the peri-
bronchial epithelia and mucus production in the lungs
of mice given OVA. OVA-challenged mice developed
marked PAS-positive goblet cell hyperplasia and mucus
hypersecretion within the bronchi in the lung (purple
colour) compared with the PBS control mice. Infection
with E. granulosus substantially decreased the number
of PAS-positive goblet cells in the peribronchial epithelia
(Figure 2A, E).
We also examined the effect of E. granulosus infection
on eosinophil major basic protein (EMBP), a constituent
of eosinophil secondary granules, that is elevated in bio-
logical fluids taken from patients with asthma and other
eosinophil-associated diseases [26]. E. granulosus infection
reduced the increased EMBP expression in lung tissues
(Figure 2C, D)) of OVA mice. Airway mucus hypersecre-
tion originates from hyperplastic goblet cells that typically
Figure 2 Effect of E. granulosus infection on OVA-induced airway inflammation and mucus production. The histological appearance of
lungs after sensitization and challenge with PBS or OVA (magnification: 200×) (A). Quantitative analyses of inflammatory cell infiltration and mucus
production in the lung (B,E). Western blotting showing relative expression of EMBP in different treatment groups (C,D). Semi-quantitative analysis of
mRNA transcripts for expression of Muc5ac (F,G). The bars indicate mean ± S.E.M. for values obtained by densitometry analysis. *p <0.05,n =8 mice/group,
in two separate experiments.
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that the expression level of Muc5ac mRNA (Figure 2F, G)
between groups was the same.
Effect of E. granulosus infection on cytokines in serum
and culture of splenocytes
To determine whether E. granulosus infection impacts on
the immune profile of systemic immunity, we measured
the concentration of cytokines in the serum and the super-
natants of splenocytes cultured in vitro. The infection in-
duced a significant increase of IL-4 and IL-10 in serum
and the culture of splenocytes, whereas, OVA induced a
significant increase of IL-17A in serum and splenocyte
supernatants compared with in the PBS control mice
(Figure 3). However, compared to OVA induced group,
the concentration of IL-17A in Eg + OVA group wasdown-regulated as shown by its reduced level in the
serum and splenocyte cultures (Figure 3).
Effect of E. granulosus infection on cytokines in the lungs
E. granulosus infection induced remarkably increased the
transcriptional levels of IFN-γ, IL-2, IL-4, IL-5 and IL-10
in the lungs (Figure 4A). However, for these infected mice
sensitized and challenged with OVA, only IFN-γ was
higher in the lung tissues than this of OVA only sensitized
and challenged mice (p <0.01) (Figure 4A); the transcrip-
tional levels of IL-4 and IL-5 in Eg +OVA mice were not
statistically different from the OVA mice. We then quanti-
fied the protein expression of the critical cytokines (IFN-γ,
IL-5) by Western blotting. IFN-γ was higher in the lung
tissue of Eg +OVA mice than that of the OVA only group
(~6.03-fold). IL-5 was also significantly induced in the lungs
Figure 3 Effects of E. granulosus infection on cytokine levels in serum and splenocytes cultured in vitro. *, p <0.05; **, p <0.01; ***, p <0.001.
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Figure 4 Cytokines in the lung tissues of mice sensitized and challenged with PBS or OVA. Cytokine mRNA expression levels were measured in
the lungs by real time PCR. AU: arbitrary units (A). Representative example of critical cytokines (IFN-γ and IL-5) measured by western blotting (WB)
(B) and densitometry of WB for expression of IFN-γ and IL-5(C,D). *, p <0 .05; **, p <0.01; ***, p <0.001. n =8 mice/group, in two separate experiments.
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regulated IL-5 expression in the lung tissues compared with
that of the OVA only mice (Figure 4B, C, D) (p <0.01).
Effect of E. granulosus infection on Treg and Th17 cells in
the OVA-induced mice
As shown earlier, E. granulosus infection reduced airway
inflammation; to determine whether Treg or Th17 cells
were involved in this phenomenon, we further evaluated
the Treg cell and Th17 cell subsets in the spleens of
mice after OVA treatment compared with those of ani-
mals without E. granulosus infection. The population of
CD4+CD25+Foxp3+ Tregs was not significantly changed
upon OVA sensitization compared with the control group.
However, the population of CD4+CD25+Foxp3+ Tregs in-
creased significantly in the E. granulosus infected mice
compared with those of the OVA mice (Figure 5A, C).
Additionally, the subset of Th17 cells in the OVA-inducedspleen was significantly higher in number than that of the
control group (Figure 5B, D).Antibody responses
Mice infected with E. granulosus had significant levels of
Th2 type immunoglobulins (IgG1 and IgE) against HCF
antigens in their sera compared with controls (p <0.001).
IgG2b was also increased (p <0.05) in response to E.
granulosus infection albeit at low levels. IgG3 levels
remained low in all mice (Figure 6A).
After the mice were sensitized and challenged with OVA,
the level of anti-OVA IgE was higher in infected than unin-
fected mice (Figure 6B). However, the OVA sensitization
and challenge suppressed the production of HCF-specific
IgG1 and IgG2b antibodies compared with their levels in E.
granulosus infected mice (p <0.05) (Figure 6B). IgG2a and
IgE levels against HCF antigens remained low.
Figure 5 Effects of E. granulosus infection on the proportion of Treg cells and Th17 cells in the spleen. Original dot plots from FACS analysis of
CD4+CD25+Foxp3+ Treg cells (A) and IL-17A+ CD4+ T cells (B) isolated from spleens. The numbers in the dot plots indicate the percent of cells within
each quadrant. C and D show the percentage of CD4+CD25+Foxp3+ Treg cells and IL-17A+ CD4+ T cells of the splenocytes. Data are mean ± SEM of
five mice, in two separate experiments. *, p <0.05; **, p <0.01.
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Asthma is a chronic inflammatory disorder character-
ized by reversible airway obstruction, bronchial hyper-
responsiveness, mucus production and eosinophilic airway
inflammation [28]. A skewing of the Th1/Th2 balance to-
wards Th2 is thought to play an important role in the de-
velopment of allergic asthma [14]. It has been shown that
E. granulosus infection regulates the host immune re-
sponse, biasing a Th1/Th2 response towards a chronic
Th2 response [15], which effectively minimizes host im-
mune attack and ensures the parasite’s survival in the
host for many years [29]. Given that a Th2 response is
a key element for causing asthma, E. granulosus infec-
tion could be considered likely to enhance an asthmatic
response. By contrast, however, the results of this currentstudy reveal that an E. granulosus infection reduced OVA-
induced pulmonary inflammation, airway mucus produc-
tion, and the number of accumulated eosinophils in BALF
and AHR in sensitized mice.
We infected mice by transplantation of small E.
granulosus cysts into the peritoneal cavity. We initially in-
fected Chinese Kunming (CKM) mice-an outbred mouse
strain. The infected animals remarkably decreased asthma
pathology responses (not shown). We then used BALB/c
mice to repeat these experiments given that the BALB/c
mouse is a recognized experimental inbred strain for aller-
gic asthma study [30]. The infection significantly gener-
ated a predominant Th2 systemic immune response, with
elevated IgG1 and IgE antibodies generated. This is similar
to the response observed in human CE infection [31-36].
Figure 6 Effects of E. granulosus infection on serum Ig production. HCF-specific serum Ig levels before and after OVA challenge (A). OVA-specific
serum Ig levels (B). *, p <0 .05; **, p <0.01; ***, p <0.001. n =5 mice/group, in two separate experiments.
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challenged with OVA showed that this allergen stimulated
a large number of infiltrating eosinophils in the peribron-
chial regions of the lung (Figure 2A). However, mice
pre-infected with E. granulosus significantly suppressed
OVA-induced allergic airway inflammation, accompanied
with peribronchial accumulation of eosinophils. In addition,
the numbers of neutrophils, macrophages, lymphocytesin
and eosinophils in BALF, PECs and blood showed that an
E. granulosus infection inhibited OVA-induced eosinophil
recruitment in the BALF. Detection of EMBP provides a
means of determining the participation of eosinophils in
the pathogenic process. We found that E. granulosus infec-
tion reduced EMBP expression in the lung tissue of OVA
challenged mice. We also found that IL-5, which plays a
critical role in the differentiation, infiltration, and activation
of pulmonary eosinophils [37], was down-regulated by
E. granulosus infection.These findings demonstrate that
an E. granulosus infection has the potential to counteractallergic asthma-associated eosinophilic airway inflamma-
tory responses.
As previously reported, we found that inoculation of
mice with E. granulosus significantly increased IgE serum
levels, which is a typical pro-allergic response [38]. It has
been suggested (the IgE blocking hypothesis) that elevated
polyclonal IgE saturates the Fcε R (IgE receptor), which
may prevent the binding of antigen-specific IgE to mast
and other cells central to atopic inflammation, resulting in
reduced atopic symptoms [17]. Unexpectedly, we found a
significant induction of OVA-specific IgE among the mice
infected with E. granulosus suggesting that induction of
polyclonal IgE is not likely to be an important mechanism
of E. granulosus -induced protection in this model;
furthermore, recent clinical studies have cast doubt on
the IgE blocking hypothesis [39-41].
In addition to the increased IgE levels in the Eg + OVA
group, subclass isotyping indicated that IgG1 antibodies
dominated the IgG response. The observation of an
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cytokine expression in serum and in supernatants of
cultured splenocytes, showing a predominance of IL-4,
indicating a polarized Th2 response is stimulated by E.
granulosus infection. OVA normally induces a predomin-
ant Th2 allergic response, so the combination would likely
increase the Th2 response. However, in contrast, our re-
sults showed that the combination of E. granulosus infec-
tion and OVA sensitization and challenge down-regulated
the Th2 response in the lungs. In addition, we identified
that E. granulosus infection induced a significant IFN-γ
production in their lung tissues. However, the combin-
ation of E. granulosus infection and OVA inhibited the ex-
pression of this cytokine and others including IL-2, IL-4,
IL-5 in the lungs compared to the E. granulosus infected
mice.
Several studies have demonstrated that IL-17 is up-
regulated in lung tissues, BAL fluids, sputum, and per-
ipheral blood of patients with allergic asthma [42-48].
In mouse models of asthma, Th17 cells enhance Th2 cell-
mediated eosinophilic airway inflammation [49] and it has
been shown that IL-17 depletion in OVA-sensitized mice
attenuates the inflammatory response [44,50]. These ob-
servations have indicated that IL-17 participates in the de-
velopment of allergic asthma. As research on the role of
IL-17 in allergic airway inflammation is still at an early
stage, there is limited literature addressing the regulation
of IL-17 and its related molecules in asthma. IL-17A is a
key pro-inflammatory cytokine in the T helper 17 pathway
[51] and it plays a critical role in host defense and inflam-
mation. Some animal studies revealed that helminthic in-
fections ameliorate the severity of autoimmune diseases
by reducing the Th17 response. In the current study, we
found that IL-17A levels were significantly increased in
OVA induced mice both in splenocyte culture and serum.
However, compared with OVA Group, the mice in Eg +
OVA Group showed a low concentration of IL-17A in
serum, implying that E. granulosus infection may down-
regulate Th17 expression.
In contrast, IL-10 was significantly higher in the Eg +
OVA group than in the OVA induced group after meas-
urement of its concentration in splenocyte culture su-
pernatants. IL-10 is a regulatory cytokine that performs
crucial functions in parasitic infections. Patients infected
with CE have a slight decrease in peripheral IL-17 and an
increase in peripheral IL-10 levels compared with healthy
controls [52]. Many previous reports have demonstrated
that the regulation of asthma reactions by parasitic in-
fection is related closely to the up-regulation of IL-10
[53-55]. IL-10 has been suggested as a treatment of asthma
because of its immunosuppressive and anti-inflammatory
properties. Recent studies have shown that the IL-10 gene
can significantly reduce the expression of IL-17 [56,57]. We
thus speculate that E. granulosus infection may decreasethe severity of allergic asthma by enhancing IL-10 expres-
sion and down-regulating the expression of IL-17A.
Conclusions
We demonstrate here that a prior infection with E.
granulosus can effectively suppress allergic airway eo-
sinophilic inflammation in an OVA-induced murine aller-
gic asthma model. Furthermore, we provide experimental
evidence that an E. granulosus infection enhances IL-10
expression and down-regulates the production of IL-17A
and IL-5, which in turn reduces the severity of OVA-
induced airway inflammation. The molecules produced by
E. granulosus which down-regulate the Th17 and IL-5
responses may prove useful agonists for prevention and
treatment of allergic asthma.
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